Polydex Pharmaceuticals Limited
POLXF
Price:
$1.986
Market Cap:
$6.82M
Polydex Pharmaceuticals Limited, through its subsidiaries, develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market worldwide. The company also manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry. It primarily offers dextran and derivative products, including iron dextran, a derivative of dextran that is injected into pigs at birth as a treatment for anemia; and dextran sulphate, a specialty chemical derivative of dextran used in biotechnology applications and the pharmaceutical industry. In addition, the company develops Ushercell, a high molecular weight cellulose sulphate for topical vaginal use primarily in...[Read more]
Industry
Biotechnology
IPO Date
1983-03-14
Stock Exchange
PNK
Ticker
POLXF
The ROE as of September 2024 (TTM) for Polydex Pharmaceuticals Limited (POLXF) is -53.04%
According to Polydex Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is -53.04%. This represents a change of 276.23% compared to the average of -14.10% of the last 4 quarters.
Polydex Pharmaceuticals Limited (POLXF) Historical ROE (quarterly & annually)
How has POLXF ROE performed in the past?
The mean historical ROE of Polydex Pharmaceuticals Limited over the last ten years is -12.98%. The current -53.04% ROE has changed 308.54% with respect to the historical average. Over the past ten years (40 quarters), POLXF's ROE was at its highest in in the April 2004 quarter at 15.85%. The ROE was at its lowest in in the January 2010 quarter at -39.89%.
Average
-12.98%
Median
-7.36%
Minimum
-63.38%
Maximum
13.33%
Polydex Pharmaceuticals Limited (POLXF) ROE by Quarter and Year
Discovering the peaks and valleys of Polydex Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 250.58%
Maximum Annual ROE = 13.33%
Minimum Annual Increase = -15449.39%
Minimum Annual ROE = -63.38%
| Year | ROE | Change |
|---|---|---|
| 2010 | -63.38% | 92.04% |
| 2009 | -33.00% | 186.48% |
| 2008 | -11.52% | 225.24% |
| 2007 | -3.54% | -81.50% |
| 2006 | -19.14% | -243.61% |
| 2005 | 13.33% | -15449.39% |
| 2004 | -0.09% | -99.22% |
| 2003 | -11.18% | 250.58% |
| 2002 | -3.19% | -269.93% |
| 2001 | 1.88% | -86.52% |
Polydex Pharmaceuticals Limited (POLXF) Average ROE
How has POLXF ROE performed in the past?
The current ROE of Polydex Pharmaceuticals Limited (POLXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-35.97%
5-year avg
-26.12%
10-year avg
-12.98%
Polydex Pharmaceuticals Limited (POLXF) ROE vs. Peers
How is POLXF’s ROE compared to its peers?
Polydex Pharmaceuticals Limited’s ROE is greater than PacificHealth Laboratories, Inc. (-54.44%), greater than ImmuCell Corporation (-16.35%), less than Senstar Technologies Ltd. (0.16%), greater than Natural Alternatives International, Inc. (-3.81%), greater than Paragon Technologies, Inc. (-2.95%),
| Company | ROE | Market cap |
|---|---|---|
| -54.44% | $438.31K | |
| -16.35% | $28.20M | |
| 0.16% | $37.76M | |
| -3.81% | $39.87M | |
| -2.95% | $10.64M |
Build a custom stock screener for Polydex Pharmaceuticals Limited (POLXF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Polydex Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Polydex Pharmaceuticals Limited (POLXF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Polydex Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Polydex Pharmaceuticals Limited's ROE?
How is the ROE calculated for Polydex Pharmaceuticals Limited (POLXF)?
What is the highest ROE for Polydex Pharmaceuticals Limited (POLXF)?
What is the 3-year average ROE for Polydex Pharmaceuticals Limited (POLXF)?
What is the 5-year average ROE for Polydex Pharmaceuticals Limited (POLXF)?
How does the current ROE for Polydex Pharmaceuticals Limited (POLXF) compare to its historical average?